文献速递眼底病与葡萄膜炎

选择性γ-分泌酶抑制剂RO4929097通过抑制Notch与ERK1/2信号通路抑制激光诱导小鼠模型中的视网膜下纤维化

RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

本研究在激光诱导的C57BL/6J小鼠脉络膜新生血管(CNV)与视网膜下纤维化模型中,于激光后1天玻璃体腔注射RO4929097(RO),并在ARPE-19及原代人RPE细胞中联合TGFβ1处理。结果显示RO缩小年轻与年老小鼠激光后第7天和第14天的CNV及视网膜下纤维化尺寸,并抑制RPE-脉络膜复合物中的上皮间质转化(EMT)与Notch激活;体外RO抑制TGFβ1诱导的Notch激活与EMT,且阻断Notch可抑制ERK1/2信号。

要点

  • 激光后1天玻璃体腔注射RO可缩小年轻与年老小鼠第7天和第14天的CNV及视网膜下纤维化尺寸。
  • RO可减轻激光诱导小鼠RPE-脉络膜复合物中的EMT与Notch激活。
  • 体外RO抑制TGFβ1诱导的ARPE-19与phRPE细胞EMT,且阻断Notch可抑制ERK1/2信号。

核心结论

  • RO通过直接抑制Notch信号并间接抑制ERK1/2信号发挥抗纤维化作用。
  • 靶向Notch信号可能为新生血管性年龄相关性黄斑变性(nAMD)视网膜下纤维化的预防和治疗提供治疗策略。

研究设计与样本

  • 研究使用雄性C57BL/6J小鼠,经激光光凝建立CNV与视网膜下纤维化模型,激光诱导后1天玻璃体腔给予RO。
  • 在2D和3D构建中测量并量化CNV与视网膜下纤维化大小。
  • 体外使用ARPE-19细胞系与原代人RPE(phRPE)细胞,以TGFβ1处理并联合或不联合RO,检测Notch相关分子、EMT、细胞活力、迁移与收缩功能及Notch与其他EMT相关信号通路的交互。

主要发现

  • 玻璃体腔注射RO缩小年轻与年老小鼠激光诱导后第7天和第14天的CNV及视网膜下纤维化尺寸。
  • RO显著减弱激光诱导小鼠RPE-脉络膜复合物中的EMT与Notch激活。
  • 体外TGFβ1激活Notch信号并诱导ARPE-19细胞EMT,伴EMT相关功能增强,RO可抑制这些变化。
  • RO对EMT的抑制作用在TGFβ1处理的phRPE细胞中进一步得到证实。
  • RO阻断Notch信号可抑制ERK1/2信号,而抑制ERK1/2对Notch无影响;RO作用不依赖Smad2/3或p38,共同抑制Notch与Smad2/3对EMT抑制显示协同效应。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to explore whether RO4929097 (RO), a specific γ-secretase inhibitor, could inhibit the subretinal fibrosis in laser-induced mouse model and the relevant molecular mechanisms. METHODS: Male C57BL/6J mice were used to produce choroidal neovascularization (CNV) and subretinal fibrosis by laser photocoagulation, and RO was administered intravitreally 1 day after laser induction. The sizes of CNV and subretinal fibrosis were measured and quantified in both 2D and 3D constructions. The ARPE-19 cell line and primary human RPE (phRPE) cells were treated with TGFβ1, in combination with or without RO, to examine Notch related molecules, epithelial mesenchymal transition (EMT), cell viability, migration, and contractile function, as well as the crosstalk between Notch and other EMT relevant signaling pathways. RESULTS: Intravitreal injection of RO reduced the sizes of both CNV and subretinal fibrosis in laser-induced young and old mice at day 7 and day 14 after laser induction. Moreover, EMT and Notch activation in RPE-choroid complexes from laser-induced mice were significantly attenuated by RO. In vitro, TGFβ1 activated Notch signaling and induced EMT in ARPE-19 cells, accompanied by enhanced EMT-related function, which were inhibited by RO. The inhibition of RO on EMT was further confirmed in TGFβ1-treated phRPE cells. Blockage of Notch signaling by RO could inhibit ERK1/2 signaling; whereas ERK1/2 inhibition had no effect on Notch. The action of RO was independent of Smad2/3 or p38, and co-inhibition of Notch and Smad2/3 showed synergistic effect on EMT inhibition. CONCLUSIONS: RO exerts its antifibrotic effect by directly inhibiting Notch signaling and indirectly suppressing ERK1/2 signaling. Targeting Notch signaling might provide a therapeutic strategy in prevention and treatment of subretinal fibrosis in neovascular age-related macular degeneration (nAMD).

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang C, Qin S, Xie H, et al. RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model. Invest Ophthalmol Vis Sci. 2022. PMID: 36155746. doi:10.1167/iovs.63.10.14

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。